Melanoma-Specific Antigens
- Name
- Melanoma-Specific Antigens
- Accession Number
- DBCAT004631
- Description
Cellular antigens that are specific for MELANOMA cells.
- Drugs
Drug Drug Description Melanoma antigen recognized by T-cells 1 Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery). GP-100 antigen GP-100 antigen is under investigation in clinical trial NCT00006385 (Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma). - Drugs & Drug Targets
Drug Target Type